CHESTERBROOK, Pa., Feb. 26, 2013 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (AUXL), a specialty biopharmaceutical company, today announced financial results for the fourth quarter and the year ended December 31, 2012. The Company also highlighted important recent commercial, regulatory and clinical development progress and provided financial guidance for 2013.
